
You Can See Everything in Their Patents
We’re looking behind the curtain of Nathan Fielder’s mind-bending documentary about Elizabeth Holmes to see what truth may be hidden in the Theranos patents. Fact, fiction, or everything in between, You Can See Everything is unquestionably a cinematic masterpiece. As of this recording, it’s shattering documentary-format expectations with over $63 million at the box office and is well on its way to becoming one of the highest-grossing documentaries of all time. Elizabeth Holmes, former Theranos Founder and now convicted felon, invites Nathan Fielder, a cult comedy icon and filmmaker, to document her life in a rented California beach house where she’s spending her final days with her children and partner before beginning her 11-year prison sentence for defrauding Theranos investors. What ensues is a psychological thriller full of pulled rugs, funhouse mirrors, and meta-narratives. It masterfully crafts a haunting and oftentimes awkwardly comedic real-time Rorschach Test around truth, manipulation, image, and media. It will leave you questioning your own susceptibility to the deception of how much your belief about another person or series of events can be totally shaped by how the story is told to you. Patents, in contrast, are a material manifestation of values and a clear articulation of the claimed boundaries of an innovation – not just what a particular investor may want to hear or what a founder may want to spin. So we decided to take a closer look at the Theranos patents to see what they could show us about how the technological claims lined up with the marketing and investor claims that took Elizabeth Holmes from one of Silicon Valley’s most celebrated self-made billionaires and black turtleneck-wearing heir apparent to Steve Jobs to a convicted felon who owes 452 million in restitution to the victims of her blood-testing fraud scheme. Her technology had been heralded as a revolution in preventive medicine that was promised to enable hundreds of diagnostic tests to be cost-effectively performed without a lab and using only a single drop of blood. The technology never fully manifested, hundreds of millions of investment dollars were lost, a company valued at $9 billion went to $0 in just a few years, and many human lives were adversely impacted by unreliable test results. Elizabeth Holmes still claims she did nothing wrong. Judges and juries disagreed. She was acquitted on patient fraud, but convicted on investor fraud. And Nathan Fielder has masterfully stirred the pot on current public perception about all of it. But what does the IP say? ** Episode Overview ** In today’s discussion, Dr. Ashley Sloat, President and Director of Patent Strategy here at Aurora, answers that question by opening up the Theranos portfolio to see how the fraudulent public claims line up with the black-and-white patent claims. Along the way, Ashley and the panel explore: ⦿ The public narrative vs. the available evidence ⦿ An overview of the Theranos portfolio and a mapping of Holmes’ platform vision to the representative patents ⦿ What Theranos actually invented, and if its patents taught anyone else how to make and use the inventions ⦿ What’s happened with the portfolio since the company's collapse, and how some of the patents have been tested ⦿ What the failure of a company can mean for the validity and value of its patents ⦿ And how some of these patents might now be viewed in light of the Amgen v. Sanofi SCOTUS decision ** Follow Aurora Patents ** ⦿ Home: https://www.aurorapatents.com/ ⦿ Twitter: https://twitter.com/AuroraPatents ⦿ LinkedIn: https://www.linkedin.com/company/aurora-cg/ ⦿ Facebook: https://www.facebook.com/aurorapatents/ ⦿ Instagram: https://www.instagram.com/aurorapatents/ ⦿ TikTok: https://www.tiktok.com/@aurorapatents ⦿ YouTube: https://www.youtube.com/@aurorapatents/ Let us know what you think about this episode!












